Nursing Home Pharmacy Billing Fraud: When the Drug and the Claim Do Not Match

Nursing home pharmacy false prescription billing occurs when a pharmacy bills a government health care program for drugs dispensed without valid prescriptions. Other pharmacy claims can misstate which drug the resident received, carrying a changed code or concealing a substituted product. Taxpayers pay for drugs without proper authorization or for a different product from the one the resident received. The order, the medication and the bill tell different stories. If you work in dispensing, pharmacy systems or billing, you may know exactly where they stopped matching and who decided to keep the claims moving.

Controlled Substances Billed Without a Physician’s Prescription

A controlled substance supplied on a nursing home staff order with no valid prescription can become a billing case when the pharmacy submits the drug claim to Medicare Part D.

The government alleged that PharMerica dispensed Schedule II drugs in nonemergency situations without prior valid physician prescriptions. Nursing-home staff orders bypassed physician authorization, and the pharmacy billed Medicare Part D for the drugs.

PharMerica’s May 2015 resolution totaled $31.5 million across the Controlled Substances Act and False Claims Act. Of that total, $23.5 million addressed the billing allegations.

A former pharmacist brought the whistleblower case, and the government joined some of its allegations. That is a useful starting point for an insider: the person who sees how a prescription is authorized may understand something the claim itself conceals. We connect the order history to the dispensing and billing records, including what management knew about the practice.

When a Nursing Home Pharmacy Changes the Drug Identification Code on a Claim

When a nursing home pharmacy changes the drug identification code on a claim, the payer can receive a description that differs from the medication dispensed. Omnicare, a national long-term-care pharmacy, faced separate cases that show how that mismatch can arise through a manual change to a rejected claim or through the design of an automated verification system.

A Rejected Claim Came Back With a Changed Code

Omnicare agreed to a combined federal and state settlement of $2.24 million in October 2016. The government alleged that employees manually altered the National Drug Code field on claims resubmitted to Medicare, Medicaid and TRICARE to overcome earlier payment rejections.

The drugs had been dispensed to patients in skilled nursing and other institutional care facilities. The alleged change happened when employees sought payment. That makes the rejected claim and its resubmission important companions to the dispensing record: they show what changed between the payer’s refusal and the pharmacy’s next request.

The case began with a former regional service-area director at Omnicare’s Lodi pharmacy. Knowledge of the billing operation, as well as knowledge of the medication, can expose the discrepancy.

Automated Verification Accepted a Less Specific Code

The larger automated-verification case ended in a May 2017 settlement for $8 million. The government alleged that Omnicare designed an automated label-verification system to increase efficiency and profit. At certain locations, its Stage II pharmacist verification used a less specific MEDID code in place of the National Drug Code.

According to the government, the system produced Medicare and Medicaid claims for generic drugs different from those actually dispensed. Patient-specific labels also showed an incorrect manufacturer or drug code. The alleged mismatch reached the claim, the label and the pharmacy’s electronic dispensing information.

That last point matters to residents as well as taxpayers. The government alleged that incorrect manufacturer and code information impaired Omnicare’s ability to track drugs and conduct recalls for individual patients. The verification system could let a product through while leaving the pharmacy with the wrong account of what it had supplied.

The person who knows why the system accepted MEDID, or how that choice carried through to labels and claims, sees a different part of the case from the employee who transmitted the bill.

Returned Nursing Home Drugs and Claims for a Different Product

Recycled medication can become a false-claim issue when the pharmacy bills the government for what it supplied. In the Med-Fast case, the civil allegations reached both medication recycled from long-term-care facilities and medication that differed from the product identified on the claim.

The Justice Department’s December 2017 account of the civil resolution described allegations that Med-Fast distributed those medications and submitted claims to Medicare. Iserve Technologies also had a civil settlement to reimburse Medicare and Medicaid for overbilling.

The same announcement described another civil billing allegation: Med-Fast sought payment from Medicare and Pennsylvania Medicaid for retail-packaged diabetes testing strips while supplying the cheaper mail-order-packaged version. The package the payer was charged for differed from the package delivered.

For an insider who sees returned nursing home drugs going back into dispensing, the useful comparison includes the original supply, the returned product and the later claim. We also examine whether a credit or reversal changed what the payer ultimately paid. The question is where the medication went and what happened to the money paid for it.

Where the Skilled Nursing Facility, Pharmacy and Payer Meet

Drugs generally fall within the bundled payment for a covered Medicare Part A skilled nursing stay. Under the Centers for Medicare & Medicaid Services’ billing manual, Medicare pays the facility, and the facility’s contract determines payment to an outside supplier. For a bundled service, the pharmacy looks to the facility for payment, rather than billing Medicare separately.

The pharmacy vendor may be affiliated with the facility or independent. We look at the supplier agreement, the entity billing for the drug and the recipient of payment together. Who supplied the drug, who billed for it and who got paid may be different businesses.

Payment arrangements also explain a neighboring pharmacy-fraud pattern. In a separate Omnicare case, the government alleged that below-cost contracts for skilled nursing facilities’ drug needs bought access to other reimbursable pharmacy business. That allegation concerns how the pharmacy won the business. The prescription and drug-code cases concern what it told the payer after dispensing.

Prescription Rollovers in Other Residential Care Settings

An expired prescription can keep generating claims when software renews the prescription number without obtaining renewed authorization. The government’s case against Omnicare and CVS described that pattern in assisted living facilities, group homes, independent living communities and other residential long-term-care settings. Those were different settings from traditional skilled nursing homes with continuous supervised medical care.

The government alleged that prescriptions continued after they expired or ran out of refills, including through an automated cycle-fill system that refilled medications in bulk. Its complaint quoted an Omnicare compliance officer describing what the software permitted:

The complaint alleged that Omnicare sent information to government payers making the dispensations appear supported by current, valid physician prescriptions. It also described pharmacists repeatedly raising concerns with management about missing refill authorization. A new prescription number allowed the process to continue while the authorization question remained unanswered.

The government announced jury damages of $135,592,814 in April 2025, with CVS also found liable for causing Omnicare to submit false claims. The later court judgment totaled $948,778,444, including multiplied damages and penalties. The prescription history and the software behavior told the same story.

What Evidence Is Needed to Prove Fraud?

We work with you to connect the actual order or product to what the payer was told and who knew about the difference. In a pharmacy healthcare fraud case, that means following the prescription history, dispensing information and claims together. For a rejected bill, we compare the original claim with its resubmission to see what changed before the pharmacy sought payment again.

Management instructions, system-design decisions and complaints from pharmacists can explain why the discrepancy continued. The Omnicare examples reach both the employee editing a claim and the people deciding what an automated check would accept. Your knowledge of those decisions can connect records that otherwise appear to describe separate tasks.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We assess the pharmacy’s practice with you, tracing the claim back to the order, product and decisions that explain it.

You Know What Left the Pharmacy

If you know why the drug, the prescription and the claim tell different stories, speak with our whistleblower experts about the pharmacy’s billing. We work beside you to build your strongest pharmacy whistleblower case and bring in pharmacy fraud whistleblower lawyers who understand prescription systems and government payment.